Importantly, peptides do not inhibit the inflammatory phase of healing that is necessary for cellular recruitment and debris clearance
After three decades and more than two hundred papers, there is still no published randomized controlled trial showing efficacy
Research interest around TB-500 often focuses on angiogenesis, cellular migration, flexibility, mobility and broader recovery mechanisms, making it a common pairing with BPC-157 in anecdotal peptide protocols
Previous studies have demonstrated that EpCAM is involved in cell junction via interacting with several important cell adhesion molecule (CAM) junctions [9]
It may help
Biomacromol 15:15431559 Han Y-Y, Liu H-Y, Han D-J, Zong X-C, Zhang S-Q, Chen Y-Q (2013) Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells